IRIS
BRAIDO, FULVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.059
Totale 18.059
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 18.059
Totale 18.059
Salva come PNG Salva come JPEG
Città #
Genova 13.168
Rapallo 1.920
Genoa 1.460
Vado Ligure 1.446
Bordighera 65
Totale 18.059
Salva come PNG Salva come JPEG
Nome #
null 200
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 170
The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners 159
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. 150
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes 149
Genuair® Usability Test: Results of a National Public Survey of the Elderly 142
A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. 140
Antiallergic drugs and quality of life. 137
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial 136
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. 134
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 134
The relationship between allergen immunotherapy and omalizumab for treating asthma 133
Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. 133
Allergic diseases and their impact on quality of life. 131
RhinAsthma patient perspective: A Rasch validation study 131
Clara cell 16 protein in COPD sputum: A marker of small airways damage? 130
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 129
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. 126
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation) 126
Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study 126
Patient-physician relationship in the management of asthma: Multicentric approach in Latin America 126
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice 125
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 124
Why do doctors and patients not follow guidelines? 123
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect 123
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). 122
Illness perception, mood and coping strategies in allergic rhinitis: are there differences among ARIA classes of severity? 122
An update on allergen immunotherapy and asthma 122
Minimal clinical important difference (MCID) of the Thai chronic urticaria quality of life questionnaire (CU-Q2oL) 122
Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol 122
New therapies for allergic rhinitis 122
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes. 122
Allergic rhinitis and asthma ad hoc survey: clinical and psychological perspectives. 121
Long-acting bronchodilators improve health related quality of life in patients with COPD. 121
Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study 121
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. 121
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 120
Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. 120
Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases 119
The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Validation and assessment 119
Quality-of-life issues in survivors to anaphylactic reactions to drugs 118
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 118
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? 118
Biosimilars in allergic diseases 118
Continuing Medical Education:an international reality 117
Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. 116
Randomized controlled trials and real life studies. Approaches and methodologies: A clinical point of view 116
Patient-reported outcomes in asthma clinical trials 116
Asthma treatment: 'magic bullets which seek their own targets'. 116
Worldwide differences on the concept of control of asthma. 115
Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? 115
From "blockbusters" to "biosimilars": An opportunity for patients, medical specialists and health care providers 114
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. 113
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR) 113
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. 113
Pidotimod: The state of art 112
Disease awareness in patients with COPD: measurement and extent 112
RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergy 112
Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) 112
Sleep disturbances in allergic diseases. 111
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context 111
Does asthma control correlate with quality of life related to upper and lower airways? A real life study. 110
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. 110
Umeclidinium for the treatment of uncontrolled asthma 110
ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. 109
"Trying, But Failing" - The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence 109
Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. 109
Cost-description and multiple imputation of missing values: the SATisfaction and adherence to COPD treatment (SAT) study 108
The link between allergic rhinitis and asthma: the united airways disease. 107
InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients--the LIAISON study protocol. 107
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 107
The ARGA study with general practitioners: Impact of medical education on asthma/rhinitis management 107
Targeted therapy for allergic asthma: predicting and evaluating response to omalizumab. 106
Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. 106
Phenotypes/endotypes-driven treatment in asthma 106
Chronic obstructive pulmonary disease patient well-being and its relationship with clinical and patient-reported outcomes: a real-life observational study. 106
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 106
Non-invasive ventilation in acute respiratory failure of patients with obesity hypoventilation syndrome 106
“ Immunologia dell’apparato Respiratorio e metodiche di studio “ Cap 8 105
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. 105
Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. 105
The relationship between asthma control and quality-of-life impairment due to chronic cough: a real-life study. 105
The anti-inflammatory properties of tiotropium 105
Impact of asthma and comorbid allergic rhinitis on quality of life and control in patients of italian general practitioners 105
Disability in moderate chronic obstructive pulmonary disease: Prevalence, burden and assessment-results from a real-life study 104
Coping with asthma: is the physician able to identify patient's behaviour? 103
Sleep apnea risk in subjects with asthma with or without comorbid rhinitis 103
Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria 103
Adherence to asthma treatments: 'We know, we intend, we advocate' 103
LABA/LAMA Fixed Dose Combination in Chronic Obstructive Pulmonary Disease: The Impact on Health-Related Quality of Life 103
The role of Pneumococcal vaccine 103
Rhinitis: Adherence to treatment and new technologies 101
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 101
Disability in COPD and its relationship to clinical and patient-reported outcomes 99
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 98
Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations 98
Patients with asthma and comorbid allergic rhinitis: is optimal quality of life achievable in real life? 97
Adherence to treatment: assessment of an unmet need in asthma. 96
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation 95
Pharmacotherapy of allergic rhinitis: current options and future perspectives 94
Totale 11.719
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.562
article - articoli 60.023
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 539
Totale 121.124
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.105 0 0 0 0 0 603 993 472 620 795 507 115
2020/20211.886 117 119 224 240 115 127 127 176 126 202 150 163
2021/20222.448 129 164 117 243 53 251 119 572 182 216 106 296
2022/20232.336 250 121 23 241 329 414 72 186 407 56 190 47
2023/20241.120 61 162 24 118 99 173 92 81 59 29 99 123
2024/20251.489 47 268 132 228 493 321 0 0 0 0 0 0
Totale 18.705